| Significance of protein binding in pharmacokinetics and pharmacodynamics S Schmidt, D Gonzalez, H Derendorf Journal of pharmaceutical sciences 99 (3), 1107-1122, 2010 | 364 | 2010 |
| Pharmacokinetic and pharmacodynamic principles of anti-infective dosing NJ Onufrak, A Forrest, D Gonzalez Clinical therapeutics 38 (9), 1930-1947, 2016 | 171 | 2016 |
| Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents D Gonzalez, S Schmidt, H Derendorf Clinical microbiology reviews 26 (2), 274-288, 2013 | 166 | 2013 |
| Drug dosing and pharmacokinetics in children with obesity: a systematic review MW Harskamp-van Ginkel, KD Hill, KC Becker, D Testoni, ... JAMA pediatrics 169 (7), 678-685, 2015 | 89 | 2015 |
| Precision dosing: public health need, proposed framework, and anticipated impact D Gonzalez, GG Rao, SC Bailey, KLR Brouwer, Y Cao, DJ Crona, ... Clinical and translational science 10 (6), 443, 2017 | 71 | 2017 |
| Therapeutic index estimation of antiepileptic drugs: a systematic literature review approach RG Greenberg, C Melloni, H Wu, D Gonzalez, L Ku, KD Hill, CP Hornik, ... Clinical neuropharmacology 39 (5), 232-240, 2016 | 69 | 2016 |
| Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents D Gonzalez, C Melloni, R Yogev, BB Poindexter, SR Mendley, P Delmore, ... Clinical Pharmacology & Therapeutics 96 (4), 429-437, 2014 | 64 | 2014 |
| Exposure matching for extrapolation of efficacy in pediatric drug development Y Mulugeta, JS Barrett, R Nelson, AT Eshete, A Mushtaq, L Yao, ... The Journal of Clinical Pharmacology 56 (11), 1326-1334, 2016 | 63 | 2016 |
| Precision dosing priority criteria: drug, disease, and patient population variables RJ Tyson, CC Park, JR Powell, JH Patterson, D Weiner, PB Watkins, ... Frontiers in Pharmacology 11, 420, 2020 | 60 | 2020 |
| Clinical pharmacology studies in critically ill children N Thakkar, S Salerno, CP Hornik, D Gonzalez Pharmaceutical research 34, 7-24, 2017 | 57 | 2017 |
| Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation KM Watt, D Gonzalez, DK Benjamin Jr, KLR Brouwer, KC Wade, ... Antimicrobial agents and chemotherapy 59 (7), 3935-3943, 2015 | 47 | 2015 |
| Pharmacokinetics of clindamycin in obese and non-obese children MJ Smith, D Gonzalez, JL Goldman, R Yogev, JE Sullivan, MD Reed, ... Antimicrobial agents and chemotherapy, AAC. 02014-16, 2017 | 43 | 2017 |
| The effect of critical illness on drug distribution D Gonzalez, D J Conrado, U Theuretzbacher, H Derendorf Current pharmaceutical biotechnology 12 (12), 2030-2036, 2011 | 43 | 2011 |
| Simulated assessment of pharmacokinetically guided dosing for investigational treatments of pediatric patients with coronavirus disease 2019 AR Maharaj, H Wu, CP Hornik, SJ Balevic, CD Hornik, PB Smith, ... JAMA pediatrics 174 (10), e202422-e202422, 2020 | 42 | 2020 |
| Association between nephrotoxic drug combinations and acute kidney injury in the neonatal intensive care unit SN Salerno, Y Liao, W Jackson, RG Greenberg, CJ McKinzie, ... The Journal of pediatrics 228, 213-219, 2021 | 41 | 2021 |
| Development of a pediatric physiologically-based pharmacokinetic model of clindamycin using opportunistic pharmacokinetic data CP Hornik, H Wu, AN Edginton, K Watt, M Cohen-Wolkowiez, D Gonzalez Clinical pharmacokinetics 56, 1343-1353, 2017 | 41 | 2017 |
| Dalbavancin pharmacokinetics and safety in children 3 months to 11 years of age D Gonzalez, JS Bradley, J Blumer, R Yogev, KM Watt, LP James, ... The Pediatric infectious disease journal 36 (7), 645-653, 2017 | 40 | 2017 |
| Pediatric drug-drug interaction studies: barriers and opportunities SN Salerno, GJ Burckart, SM Huang, D Gonzalez Clinical pharmacology and therapeutics 105 (5), 1067, 2019 | 37 | 2019 |
| Clindamycin pharmacokinetics and safety in preterm and term infants D Gonzalez, P Delmore, BT Bloom, CM Cotten, BB Poindexter, ... Antimicrobial agents and chemotherapy 60 (5), 2888-2894, 2016 | 37 | 2016 |
| Population pharmacokinetics of trimethoprim-sulfamethoxazole in infants and children J Autmizguine, C Melloni, CP Hornik, S Dallefeld, B Harper, R Yogev, ... Antimicrobial agents and chemotherapy 62 (1), 10.1128/aac. 01813-17, 2018 | 36 | 2018 |
Daniel K BenjaminProfessor of Pediatrics, Duke UniversityVerified email at duke.edu
